Global Diabetes Market Report: 2014 Edition
Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. Diabetes is a disorder of metabolism, the process by which the body uses digested food for energy. The digestive tract breaks down carbohydrates, sugars and starches found in many foods, into glucose, a form of sugar that enters the bloodstream. Type 1 diabetes, Type 2 diabetes and Gestational diabetes are the three types of diabetes. There are mainly three types of diabetes treatment which include insulin, oral antidiabetic drug (OAD) and glucagon-like-peptide-1 (GLP-1).
The key factors which are anticipated to drive market growth include increasing aging population, rising obese population, rising healthcare expenditure, and continuously surging urban population. Some of the noteworthy developments of this industry include sedentary lifestyle, family history and genetics, among others. However, the industry remains threatened by certain challenges which include high diabetes cost which is a huge burden for families.
This report offers a comprehensive analysis of the global diabetes market, along with an in-depth study of the regional market including the US, China, Japan, UK and India. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global diabetes market is reined by few major players namely, Novo-Nordisk, Takeda, Sanofi-Aventis and Eli Lilly. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
The key factors which are anticipated to drive market growth include increasing aging population, rising obese population, rising healthcare expenditure, and continuously surging urban population. Some of the noteworthy developments of this industry include sedentary lifestyle, family history and genetics, among others. However, the industry remains threatened by certain challenges which include high diabetes cost which is a huge burden for families.
This report offers a comprehensive analysis of the global diabetes market, along with an in-depth study of the regional market including the US, China, Japan, UK and India. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global diabetes market is reined by few major players namely, Novo-Nordisk, Takeda, Sanofi-Aventis and Eli Lilly. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. INTRODUCTION TO DIABETES
2. GLOBAL DIABETES MARKET
Diabetic Population
Prevalence Rates
Treatment Market Value
Insulin Market Value
Insulin Segments
Breakdown by Region
3. REGIONAL ANALYSIS
3.1 The Western Pacific
3.1.1 China
3.1.2 Japan
3.2.3 Other Countries
3.2 South-East Asia
3.2.1 India
3.2.2 Other Countries
3.3 Europe
3.3.1 United Kingdom
3.3.2 Other Countries
3.4 North America and Caribbean
3.4.1 The US
3.4.2 Other Countries
3.5 Middle East and North Africa
3.5.1 Other Countries
3.6 South and Central America
3.6.1 Other Countries
3.7 Africa
3.7.1 Other Countries
4. MARKET DYNAMICS
4.1 Key Trends
4.1.1 Sedentary Lifestyle
4.1.2 Family History and Genetics
4.1.3 Increasing Prevalence of Diabetes
4.2 Growth Drivers
4.2.1 Increasing Aging Population
4.2.2 Increasing Urbanization
4.2.3 Rising Healthcare Expenditure
4.2.4 Rising Obese Population
4.3 Challenges
4.3.1 Lack of Sufficient Diagnosis and Treatment
4.3.2 Diabetes Cost - A Burden for Family and Society
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.2 Regional
5.2.1 The US
5.2.2 Europe
5.2.3 China
5.2.4 Japan
6. COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
Product Innovation
Leadership in Growth Disorders
6.2 Takeda
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
Research & Development Strategy
Product Innovation
6.3 Sanofi-Aventis
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
Growth through Acquisitions
Launching Innovative Products
6.4 Eli Lilly
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
Acquisition Policy
Research & Development Strategy
?
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
2. GLOBAL DIABETES MARKET
Diabetic Population
Prevalence Rates
Treatment Market Value
Insulin Market Value
Insulin Segments
Breakdown by Region
3. REGIONAL ANALYSIS
3.1 The Western Pacific
3.1.1 China
3.1.2 Japan
3.2.3 Other Countries
3.2 South-East Asia
3.2.1 India
3.2.2 Other Countries
3.3 Europe
3.3.1 United Kingdom
3.3.2 Other Countries
3.4 North America and Caribbean
3.4.1 The US
3.4.2 Other Countries
3.5 Middle East and North Africa
3.5.1 Other Countries
3.6 South and Central America
3.6.1 Other Countries
3.7 Africa
3.7.1 Other Countries
4. MARKET DYNAMICS
4.1 Key Trends
4.1.1 Sedentary Lifestyle
4.1.2 Family History and Genetics
4.1.3 Increasing Prevalence of Diabetes
4.2 Growth Drivers
4.2.1 Increasing Aging Population
4.2.2 Increasing Urbanization
4.2.3 Rising Healthcare Expenditure
4.2.4 Rising Obese Population
4.3 Challenges
4.3.1 Lack of Sufficient Diagnosis and Treatment
4.3.2 Diabetes Cost - A Burden for Family and Society
5. COMPETITIVE LANDSCAPE
5.1 Global Market
5.2 Regional
5.2.1 The US
5.2.2 Europe
5.2.3 China
5.2.4 Japan
6. COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
Product Innovation
Leadership in Growth Disorders
6.2 Takeda
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
Research & Development Strategy
Product Innovation
6.3 Sanofi-Aventis
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
Growth through Acquisitions
Launching Innovative Products
6.4 Eli Lilly
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
Acquisition Policy
Research & Development Strategy
?
7. MARKET OUTLOOK
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis
LIST OF CHARTS
Types of diabetes
Global Diabetic Population (2006-2013)
Global Diabetic Population by Region (2013)
Global Diabetes Prevalence Rates (2013)
Diabetes Market by Treatment Product (2013)
Global Diabetes Care Market by Treatment Class in Value Terms (Feb 2014)
Global Insulin Market Growth (Feb 2009-Feb 2014)
Global Insulin Market Share by Molecule (2013)
Global Insulin Market by Segments (2013)
Global Insulin Market by Geographical Segments (2013)
Insulin Pump Therapy for Type 1 Diabetes (2013)
Insulin Pump Therapy for Type 2 Insulin-Dependent Diabetics (2013)
Global Share of Long Acting Insulin Volume by Region (2013)
Global Share of Rapid Acting Insulin Volume by Region (2013)
Global GLP-1 Market by Geographical Segments (2013)
Number of Diabetes Cases among Chinese Adults 20 Years of Age or Older (2013)
Diabetes Cases in China – Demographic Trends (2013)
Prevalence of Diabetes among Chinese Adults by Gender (2013)
Prevalence of Diabetes and Prediabetes by Body Mass Index in Chinese Population (2013)
Chinese Insulin Market by Segments (2013)
Japanese Insulin Market by Segments (2013)
European Insulin Market by Segments (2013)
Number of People with Diabetes in Scotland (2001–2013)
Type of Diabetes in Scotland (2013)
The US Diabetic Market by Value (2006-2013)
Diagnosed Patients on Insulin and Other Medications in the US (2013)
US Insulin Pump and CGM Use for Type 1 Diabetes (2008-2013)
The US Insulin Market (2014-2030)
No. of Children (0-14 years) with Type 1 Diabetes by Region (2013)
Ageing Population Worldwide (2008-2013)
Global Urban Population (2008-2013)
Global Healthcare Expenditure Per Capita (2008-2013)
Growth in Worldwide Obese Population (2004-2013E)
Global Diabetes Market Share by Company (2013)
Global Insulin Market Share by Value (2013)
Global Insulin Pump Market Share (2013)
Global Blood Glucose Testing Market Share (2013)
Modern Insulin Market in the US by Value (2013)
Modern Insulin Market in Europe by Volume (2013)
Insulin Market Share In China by Volume (2013)
Modern Insulin Market Share In Japan by Volume (2013)
Novo Nordisk’s Revenue Share by Business Segments (2013)
Novo Nordisk’s Revenue Share by Region (2013)
Novo Nordisk’s Sales and Profit (2009-2013)
Takeda’s Revenue Share by Business Segments (2013)
Takeda’s Revenue Share by Region (2013)
Takeda’s Net Sales and Profit (2009-2014)
Sanofi-Aventis’s Revenue Share by Business Segment (2013)
Sanofi-Aventis’s Revenue Share by Region (2013)
Sanofi Aventis Net Sales and Profit (2009-2013)
Eli Lilly’s Revenue Share by Business Segments (2013)
Eli Lilly’s Revenue Share by Region (2013)
Eli Lilly’s Net Sales and Profit (2009-2013)
Global Diabetic Population (2011-2016F)
Types of diabetes
Global Diabetic Population (2006-2013)
Global Diabetic Population by Region (2013)
Global Diabetes Prevalence Rates (2013)
Diabetes Market by Treatment Product (2013)
Global Diabetes Care Market by Treatment Class in Value Terms (Feb 2014)
Global Insulin Market Growth (Feb 2009-Feb 2014)
Global Insulin Market Share by Molecule (2013)
Global Insulin Market by Segments (2013)
Global Insulin Market by Geographical Segments (2013)
Insulin Pump Therapy for Type 1 Diabetes (2013)
Insulin Pump Therapy for Type 2 Insulin-Dependent Diabetics (2013)
Global Share of Long Acting Insulin Volume by Region (2013)
Global Share of Rapid Acting Insulin Volume by Region (2013)
Global GLP-1 Market by Geographical Segments (2013)
Number of Diabetes Cases among Chinese Adults 20 Years of Age or Older (2013)
Diabetes Cases in China – Demographic Trends (2013)
Prevalence of Diabetes among Chinese Adults by Gender (2013)
Prevalence of Diabetes and Prediabetes by Body Mass Index in Chinese Population (2013)
Chinese Insulin Market by Segments (2013)
Japanese Insulin Market by Segments (2013)
European Insulin Market by Segments (2013)
Number of People with Diabetes in Scotland (2001–2013)
Type of Diabetes in Scotland (2013)
The US Diabetic Market by Value (2006-2013)
Diagnosed Patients on Insulin and Other Medications in the US (2013)
US Insulin Pump and CGM Use for Type 1 Diabetes (2008-2013)
The US Insulin Market (2014-2030)
No. of Children (0-14 years) with Type 1 Diabetes by Region (2013)
Ageing Population Worldwide (2008-2013)
Global Urban Population (2008-2013)
Global Healthcare Expenditure Per Capita (2008-2013)
Growth in Worldwide Obese Population (2004-2013E)
Global Diabetes Market Share by Company (2013)
Global Insulin Market Share by Value (2013)
Global Insulin Pump Market Share (2013)
Global Blood Glucose Testing Market Share (2013)
Modern Insulin Market in the US by Value (2013)
Modern Insulin Market in Europe by Volume (2013)
Insulin Market Share In China by Volume (2013)
Modern Insulin Market Share In Japan by Volume (2013)
Novo Nordisk’s Revenue Share by Business Segments (2013)
Novo Nordisk’s Revenue Share by Region (2013)
Novo Nordisk’s Sales and Profit (2009-2013)
Takeda’s Revenue Share by Business Segments (2013)
Takeda’s Revenue Share by Region (2013)
Takeda’s Net Sales and Profit (2009-2014)
Sanofi-Aventis’s Revenue Share by Business Segment (2013)
Sanofi-Aventis’s Revenue Share by Region (2013)
Sanofi Aventis Net Sales and Profit (2009-2013)
Eli Lilly’s Revenue Share by Business Segments (2013)
Eli Lilly’s Revenue Share by Region (2013)
Eli Lilly’s Net Sales and Profit (2009-2013)
Global Diabetic Population (2011-2016F)
LIST OF TABLES
Insulin Market by Region (2013-2014)
Western Pacific - Diabetes Statistics (2013)
China - Diabetes Statistics (2013)
Japan - Diabetes Statistics (2013)
Diabetes in Other Major Countries of Western Pacific (2013)
South-East Asia – Diabetes Statistics (2013)
India – Diabetes Statistics (2013)
Diabetes in Other Countries of South East Asia (2013)
Europe – Diabetes Statistics (2013)
United Kingdom – Diabetes Statistics (2013)
Diabetes in UK – Regional Analysis (2013)
Diabetes Prevalence in England, Wales and Scotland by Age Group (2013)
Age Group of People with Type 1 & Type 2 Diabetes in Scotland (2013)
New Cases (per 100,000 populations per year) of Type 1 Diabetes by Age in Scotland (2009-2013)
New Cases (per 100,000 populations per year) of Type 2 Diabetes by Age in Scotland (2009-2013)
Diabetes in Other Countries of Europe (2013)
North America and Caribbean – Diabetes Statistics (2013)
Diabetes in the US (2010-2013E)
Incidence of Obesity in the US
Diabetes in Other Countries of the North American and Caribbean Region (2013)
Middle East and North Africa – Diabetes Statistics (2013)
Diabetes in Other Countries of the Middle East and North Africa Region (2013)
South and Central America – Diabetes Statistics (2013)
Diabetes in Other Countries of the South and Central America Region (2013)
Africa – Diabetes Statistics (2013)
Diabetes in Other Countries of Africa Region (2013)
Dependent & Independent Variables (2008– 2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Insulin Market by Region (2013-2014)
Western Pacific - Diabetes Statistics (2013)
China - Diabetes Statistics (2013)
Japan - Diabetes Statistics (2013)
Diabetes in Other Major Countries of Western Pacific (2013)
South-East Asia – Diabetes Statistics (2013)
India – Diabetes Statistics (2013)
Diabetes in Other Countries of South East Asia (2013)
Europe – Diabetes Statistics (2013)
United Kingdom – Diabetes Statistics (2013)
Diabetes in UK – Regional Analysis (2013)
Diabetes Prevalence in England, Wales and Scotland by Age Group (2013)
Age Group of People with Type 1 & Type 2 Diabetes in Scotland (2013)
New Cases (per 100,000 populations per year) of Type 1 Diabetes by Age in Scotland (2009-2013)
New Cases (per 100,000 populations per year) of Type 2 Diabetes by Age in Scotland (2009-2013)
Diabetes in Other Countries of Europe (2013)
North America and Caribbean – Diabetes Statistics (2013)
Diabetes in the US (2010-2013E)
Incidence of Obesity in the US
Diabetes in Other Countries of the North American and Caribbean Region (2013)
Middle East and North Africa – Diabetes Statistics (2013)
Diabetes in Other Countries of the Middle East and North Africa Region (2013)
South and Central America – Diabetes Statistics (2013)
Diabetes in Other Countries of the South and Central America Region (2013)
Africa – Diabetes Statistics (2013)
Diabetes in Other Countries of Africa Region (2013)
Dependent & Independent Variables (2008– 2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
